Skip to main content
. 2021 Dec 21;8:805228. doi: 10.3389/fmolb.2021.805228

FIGURE 3.

FIGURE 3

Synthesis, application, and pharmacokinetics of erythrocyte membrane-cloaked metal–organic frameworks (MOF), TGZ@eM. (A) Schematic illustration of TGZ@eM synthesis. (B) Application diagram of TGZ@eM in cancer treatment. (C) In vivo pharmacokinetics of TGZ@eM and TGZ. (D) Biodistribution of TGZ@eM and TGZ. (E) Blood glucose level of mice during daytime after injection with TGZ@eM. Reproduced with permission. Copyright 2018, ACS Nano.